Prognostic factors and overall survival of breast cancer in Benin: a hospital-based study.

Autor: Gnangnon, Freddy Houéhanou Rodrigue^1,2,3,4 (AUTHOR) fredgnang@yahoo.fr, Parenté, Alexis^1,3 (AUTHOR), Aboubakar, Moufalilou⁵ (AUTHOR), Kiki-migan, Yannick¹ (AUTHOR), Totah, Terence¹ (AUTHOR), Gbessi, Dansou Gaspard² (AUTHOR), Tonato-Bagnan, Josiane Angéline⁶ (AUTHOR), Laleye, Anatole⁷ (AUTHOR), Preux, Pierre-Marie³ (AUTHOR), Denakpo, Justin Lewis⁵ (AUTHOR), Blanquet, Véronique³ (AUTHOR), Houinato, Dismand Stephan^1,3 (AUTHOR)

Publikováno v: BMC Women's Health. 5/18/2024, Vol. 24 Issue 1, p1-11. 11p.

Response shift results of quantitative research using patient-reported outcome measures: a descriptive systematic review.

Autor: Sawatzky, Richard^1,2,3 (AUTHOR) rick.sawatzky@twu.ca, Sajobi, Tolulope T.⁴ (AUTHOR), Russell, Lara^1,2 (AUTHOR), Awosoga, Oluwagbohunmi A.⁵ (AUTHOR), Ademola, Ayoola⁴ (AUTHOR), Böhnke, Jan R.⁶ (AUTHOR), Lawal, Oluwaseyi⁴ (AUTHOR), Brobbey, Anita⁴ (AUTHOR), Lix, Lisa M.⁷ (AUTHOR), Anota, Amelie⁸ (AUTHOR), Sebille, Véronique⁹ (AUTHOR), Sprangers, Mirjam A. G.^10,11 (AUTHOR), Verdam, Mathilde G. E.^10,11,12 (AUTHOR)

Publikováno v: Quality of Life Research. Feb2024, Vol. 33 Issue 2, p293-315. 23p.

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

Autor: Bellera CA; Clinical and Epidemiological Research Unit, Institut Bergonie, Comprehensive Cancer Centre, Bordeaux; Clinical Epidemiology Unit, INSERM CIC 14.01 (Clinical Epidemiology), Bordeaux. Electronic address: c.bellera@bordeaux.unicancer.fr., Penel N; Department of Medical Oncology, Centre Oscar Lambret, Comprehensive Cancer Centre, Lille, France., Ouali M; Department of Biostatistics, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Biostatistics Unit, Institut Claudius Regaud, Comprehensive Cancer Centre, Toulouse., Bonvalot S; Department of Surgery, Institut Gustave Roussy, Comprehensive Cancer Centre, Villejuif, France., Casali PG; Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Nielsen OS; Faculty of Health Sciences, Aarhus University, Aarhus, Denmark., Delannes M; Department of Radiotherapy, Institut Claudius Régaud, Comprehensive Cancer Center, Toulouse., Litière S; Department of Biostatistics, European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Bonnetain F; Methodological and Quality of Life Unit in Oncology (EA3181), CHU Besançon, Besançon., Dabakuyo TS; Biostatistics and Quality of Life Unit (EA4184), Centre Georges-François Leclerc, Comprehensive Cancer Centre, Dijon, France., Benjamin RS; Division of Cancer Medicine and Sarcoma Center, The University of Texas M.D. Anderson Cancer Center, Houston, USA., Blay JY; Department of Medical Oncology, Centre Léon Bérard, Comprehensive Cancer Centre, Lyon; Claude Bernard Lyon I University, Lyon; Medical Oncology Unit, Edouard Herriot Hospital, Lyon., Bui BN; Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux., Collin F; Department of Biology and Pathology, Centre Georges-François Leclerc, Comprehensive Cancer Centre, Dijon, France., Delaney TF; Department of Radiation Oncology and Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, USA., Duffaud F; Department of Medical Oncology, La Timone Hospital University, Marseille, France., Filleron T; Biostatistics Unit, Institut Claudius Regaud, Comprehensive Cancer Centre, Toulouse., Fiore M; Department of Surgery and Sarcoma Unit, Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gelderblom H; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands., George S; Department of Medical Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Grimer R; Royal Orthopaedic Hospital NHS Trust, Birmingham, UK., Grosclaude P; Cancer Registry of Tarn, Institut Claudius Regaud, Comprehensive Cancer Centre, Toulouse, France., Gronchi A; Department of Surgery and Sarcoma Unit, Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Haas R; Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Hohenberger P; Division of Surgical Oncology and Thoracic Surgery, Mannheim University Medical Center, Mannheim., Issels R; Sarcoma Center, Ludwig-Maximilian University Munich, Munich; Department of Internal Medicine, Klinikum Grosshadern Medical Center, University of Munich, Munich, Germany., Italiano A; Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux., Jooste V; Burgundy Digestive Cancer Registry, INSERM U866, University of Burgundy, Dijon, France., Krarup-Hansen A; Department of Oncology, Herlev Hospital-University Copenhagen, Herlev, Denmark., Le Péchoux C; Department of Radiotherapy, Institut Gustave Roussy, Comprehensive Cancer Centre, Villejuif, France., Mussi C; Department of Surgery, Humanitas Clinical and Research Center, Rozzano, Milan, Italy., Oberlin O; Department of Surgery and Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, Comprehensive Cancer Centre, Villejuif., Patel S; Division of Cancer Medicine and Sarcoma Center, The University of Texas M.D. Anderson Cancer Center, Houston, USA., Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Comprehensive Cancer Centre, Paris, France., Raut C; Department of Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Ray-Coquard I; Department of Medical Oncology, Centre Léon Bérard, Comprehensive Cancer Centre, Lyon., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Schuetze S; Department of Medical Oncology, University of Michigan, Ann Arbor, USA., Sleijfer S; Department of Medical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands., Stoeckle E; Department of Surgical Oncology, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France., Van Glabbeke M; Department of Biostatistics, European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Woll P; Department of Oncology, Sheffield Cancer Research Centre, Weston Park Hospital, Sheffield, UK., Gourgou-Bourgade S; Montpellier Cancer Institute, Comprehensive Cancer Centre, Montpellier, France., Mathoulin-Pélissier S; Clinical and Epidemiological Research Unit, Institut Bergonie, Comprehensive Cancer Centre, Bordeaux; Clinical Epidemiology Unit, INSERM CIC 14.01 (Clinical Epidemiology), Bordeaux.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2015 May; Vol. 26 (5), pp. 865-872. Date of Electronic Publication: 2014 Jul 28.

Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma.

Autor: Chen, Yen-Hao^1,2,3,4 (AUTHOR) alex8701125@gmail.com, Tsai, Ching-Hua⁵ (AUTHOR), Chen, Yen-Yang¹ (AUTHOR), Wang, Chih-Chi⁶ (AUTHOR), Wang, Jing-Houng⁷ (AUTHOR), Hung, Chao-Hung⁷ (AUTHOR), Kuo, Yuan-Hung⁷ (AUTHOR)

Publikováno v: BMC Cancer. 8/29/2023, Vol. 23 Issue 1, p1-10. 10p.

Impact of neoadjuvant chemotherapy on survival in breast cancer patients in daily practice: a population-based study.

Autor: Dabakuyo TS; Breast and Gynecologic Cancer Registry of Côte d'Or, Centre Georges François Leclerc, Dijon, EA 4184, France. sdabakuyo@cgfl.fr, Arnaud A, Maingon P, Causeret S, Coudert B, Fumoleau P, Arnould L, Poillot ML, Arveux P, Crehange G, Bonnetain F

Publikováno v: European journal of cancer care [Eur J Cancer Care (Engl)] 2013 Sep; Vol. 22 (5), pp. 638-47. Date of Electronic Publication: 2013 May 05.